Dr. Fausto Panizzolo, PhD and MSC; Margherita Mendicino, BSC; Simone Cimino, BSC; Samuel Mazzolin, MSC; Carlotta Damioli, High School Graduate; Anna Iannaci, High School Graduate | Moveo Srl
Competition Sponsor: EIT Health of the European Union
Awardee Year: 2022
ExoBand soft exoskeleton is a revolutionary approach to support physical therapy treatments in medical conditions derived from degenerative diseases (Multiple Sclerosis or Parkinson’s disease above all), aging or injured patients. It enhances mobility and allows remote rehabilitation and physiotherapy, with consequent benefits for health, cost savings and improved quality of life. Results of tests carried out confirmed that ExoBand strongly reduces the need for exertion by the user for walking and with a few weeks of training, patients can increase the distance walked by up to 50%, with an average increase of 15-20%.
Moveo holds the IPR to manufacture and exploit ExoBand thanks to two patent applications, filed to protect the IP generated from the new product development.
ExoBand is unique: it does not require any power, being based on a mechanical passive mechanism, it is lightweight, wearable and affordable. In Italy it can be fully reimbursed through national healthcare service and Moveo is going through the reimbursement process in other EU countries as well. ExoBand supports both patients and professionals in rehabilitation and physiotherapy programmes. It strongly improves the quality of life of: 1) People with degenerative disease. Prolonging the active life of PD, post-stroke and MS patients has a major impact on their quality of life, in addition to the savings associated with deferring immobility and socio-economic benefits due to their working activity.
To learn more about this proposal, email healthylongevity@nas.edu.